TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer.

Aranzazu Fernandez-Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.